• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

MVM Life Science Partners

edit

MVM was founded in 1997 and manages three funds totalling more than US$500 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.

Recent Milestones

edit

• 
  MVM Life Science Partners invested in eZono. (1/3/13)
  Posted 1/3/13 at 8:00pm via finsmes.com
• 
  MVM Life Science Partners invested in Tarsa Therapeutics. (3/16/12)
  Posted 3/16/12 at 5:50am via prnewswire.com
• 
  MVM Life Science Partners invested in Horizon Discovery. (1/16/12)
  Posted 1/15/12 at 11:46pm via onbiovc.com
• 
  MVM Life Science Partners invested in Beacon Endoscopic. (8/1/11)
  Posted 8/1/11 at 5:27pm via masshightech.com
• 
  MVM Life Science Partners invested in AccuVein. (7/28/11)
  Posted 7/28/11 at 7:25pm via finsmes.com
• 
  MVM Life Science Partners invested in Vantia Therapeutics. (7/6/11)
  Posted 7/6/11 at 6:56pm via vantiatherapeutics.com
• 
  MVM Life Science Partners invested in Vascular Pathways. (11/1/10)
  Posted 11/1/10 at 9:52pm via finsmes.com
• 
  MVM Life Science Partners invested in Cara Therapeutics. (7/21/10)
  Posted 7/21/10 at 6:59pm via fiercebiotech.com
• 
  MVM Life Science Partners invested in Cheetah Medical. (4/6/10)
  Posted 4/5/10 at 11:05pm via onbiovc.com
• 
  MVM Life Science Partners invested in Tarsa Therapeutics. (1/17/10)
  Posted 1/19/10 at 11:35pm via onbiovc.com
• 
  MVM Life Science Partners invested in BioVex. (11/10/09)
  Posted 11/10/09 at 3:39pm via xconomy.com
• 
  MVM Life Science Partners invested in Cara Therapeutics. (11/28/06)
  Posted 4/20/10 at 4:28am via thefreelibrary.com

Investments

Videos

Sources

1. MVM Life Science Partners to Raise $225M Medtech Fund This Year (pevc.dowjones.com) [edit]
2. eZono Raises $10M in Funding (finsmes.com) [edit]
3. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin (prnewswire.com) [edit]
4. Horizon Discovery, Ltd.: Series C $18.6M (onbiovc.com) [edit]
5. Beacon Endoscopic draws $8M in two fundings (masshightech.com) [edit]
6. AccuVein Secures $22.5M in Series B Financing (finsmes.com) [edit]
7. Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds (vantiatherapeutics.com) [edit]
8. Vascular Pathways Closes $14M Series B Financing (finsmes.com) [edit]
9. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
10. Cheetah Medical, Inc.: Series B $20M (onbiovc.com) [edit]
11. Tarsa Therapeutics, Inc.: Series A $24M (onbiovc.com) [edit]
12. Xconomy Boston (xconomy.com) [edit]
13. Cara Therapeutics Secures $19 Million in Series C Financing. (thefreelibrary.com) [edit]